Genetic analysis of coronary artery disease single-nucleotide polymorphisms in diabetic nephropathy

Nephrology Dialysis Transplantation

Volumn 24, Issue 8, 2009, Pages 2473-2476

  McKnight, Amy Jayne ^a   Maxwell, Alexander P ^a   Fogarty, Damian G ^a   Sadlier, Denise ^b   Savage, David A ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Apolipoprotein; Association; Diabetic nephropathy; Genetics; Single nucleotide polymorphisms

Indexed keywords

INSULIN;

ADOLESCENT; ADULT; ARTICLE; CHROMOSOME 19Q; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETIC NEPHROPATHY; GENETIC ANALYSIS; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 67651092218     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp015     Document Type: Article

References (16)

1. Ansell D, Feehally J, Feest TG et al. UK Renal Registry Report 2007. UK Renal Registry, Bristol, UK: 2007
2. Tuomilehto J, Borch-Johnsen K, Molarius A et al. Incidence of cardiovascular disease in type 1 (insulin-dependent) diabetic subjects with and without diabetic nephropathy in Finland. Diabetologia 1998; 41: 784-790
3. Lindsay RS, Little J, Jaap AJ et al. Diabetic nephropathy is associated with an increased familial risk of stroke. Diabetes Care 1999; 22: 422-425
4. Thorn LM, Forsblom C, Fagerudd J et al. Clustering of risk factors in parents of patients with type 1 diabetes and nephropathy. Diabetes Care 2007; 30: 1162-1167
5. Department of Health. National Service Frameworks, 2006. http://www.dh.gov.uk
6. Savage DA, Bain SC, McKnight AJ et al. Gene discovery in diabetic nephropathy. Curr Diab Rep 2007; 7: 139-145
7. McKnight AJ, O'Donoghue D, Maxwell AP. Annotated chromosome maps for renal disease. Hum Mutat 2008; 0: 1-8, DOI: 10.1002/humu.20885
8. Wellcome Trust Case Control Consortium. Genome-wide association study of 14 000 cases of seven common diseases and 3000 shared controls. Nature 2007; 447: 661-678
9. Samani NJ, Erdmann J, Hall AS et al. Genome-wide association analysis of coronary artery disease. N Engl J Med 2007; 357: 443-453
10. McPherson R, Pertsemlidis A, Kavaslar N et al. A common allele on chromosome 9 associated with coronary heart disease. Science 2007; 316: 1488-1491
11. Currie D, Maxwell AP, Sadlier D et al. for the Warren 3/UK GoKinD Study Group. Investigation of Adducin 2 (beta) DNA polymorphisms in genetic predisposition to diabetic nephropathy in type 1 diabetes. Diabet Med 2008; 25: 1001-1005
12. McKnight AJ, Savage DA, Patterson CC et al. Resequencing of genes for transforming growth factor beta1 (TGFB1) type 1 and 2 receptors (TGFBR1, TGFBR2), and association analysis of variants with diabetic nephropathy. BMC Med Genet 2007; 8: 5
13. Purcell S, Neale B, Todd-Brown K et al. PLINK: a tool set for wholegenome association and population-based linkage analyses. Am JHum Genet 2007; 81: 559-575. http://pngu.mgh.harvard.edu/purcell/plink/
14. Koopmans SJ, Jong MC, Que I et al. Hyperlipidaemia is associated with increased insulin-mediated glucose metabolism, reduced fatty acid metabolism and normal blood pressure in transgenic mice overexpressing human apolipoprotein C1. Diabetologia 2001; 44: 437-443
15. Hirano T, Sakaue T, Misaki A et al. Very low-density lipoprotein-apoprotein CI is increased in diabetic nephropathy: comparison with apoprotein CIII. Kidney Int 2003; 63: 2171-2177
16. Li H, Wetten S, Li L et al. Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Arch Neurol 2008; 65: 45-53